Literature DB >> 21321105

A polymorphism in the coding region of Il12b promotes IL-12p70 and IL-23 heterodimer formation.

Antonie Zwiers1, Ivan J Fuss, Diana Seegers, Tanja Konijn, Juan J Garcia-Vallejo, Janneke N Samsom, Warren Strober, Georg Kraal, Gerd Bouma.   

Abstract

IL-12 and IL-23 are heterodimeric cytokines involved in the induction of Th1 and Th17 immune responses. Previous work indicated that a region on chromosome 11 encoding the IL-12p40 subunit regulates strain differences in susceptibility to murine trinitrobenzene sulfonic acid-induced colitis. In addition, this region determines strain differences in LPS-induced IL-12 responses. In this study, we investigated how polymorphisms in the coding region of murine Il12b influence IL-12 and IL-23 heterodimer formation. Transfection studies using constructs containing IL-12p35 linked to IL-12p40 from the colitis-resistant C57BL/6 strain or to the polymorphic p40 variant from the colitis-susceptible SJL/J strain demonstrated that SJL/J-derived p40 constructs synthesized significantly more IL-12p70 than did constructs harboring the C57BL/6-p40 variant. This could not be attributed to differences in synthesis rate or secretion, implicating a greater affinity of SJL/J-derived IL-12p40 for its IL-12p35 subunit. This greater affinity is also associated with increased IL-23 synthesis. In addition, C57BL/6 mice transgenic for the SJL/J 40 variant synthesized significantly more IL-12p70 upon LPS challenge and were more prone to develop colonic inflammation than did C57BL/6 mice transgenic for the C57BL/6-p40 variant. The more efficient binding of the polymorphic Il12b variant to p35 and p19 is most likely due to conformational changes following differential glycosylation as a consequence of the polymorphism. The high synthesis rate of the mature cytokines resulting from this efficient binding can lead to rapid proinflammatory skewing of immune responses and distortion of the homeostatic balance underlying the greater susceptibility for colitis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321105      PMCID: PMC3673698          DOI: 10.4049/jimmunol.1001330

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses.

Authors:  Anders Ekbom; Scott M Montgomery
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-06       Impact factor: 3.043

2.  The IL12B gene is associated with asthma.

Authors:  Adrienne G Randolph; Christoph Lange; Edwin K Silverman; Ross Lazarus; Eric S Silverman; Benjamin Raby; Alison Brown; Al Ozonoff; Brent Richter; Scott T Weiss
Journal:  Am J Hum Genet       Date:  2004-08-20       Impact factor: 11.025

3.  Regulation of interleukin 12 p40 expression through an NF-kappa B half-site.

Authors:  T L Murphy; M G Cleveland; P Kulesza; J Magram; K M Murphy
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

4.  Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children.

Authors:  Grant Morahan; Dexing Huang; Mark Wu; Barbara J Holt; Gregory P White; Garth E Kendall; Peter D Sly; Patrick G Holt
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

5.  Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses.

Authors:  Gerd Bouma; Anjali Kaushiva; Warren Strober
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

Review 6.  The immunological and genetic basis of inflammatory bowel disease.

Authors:  Gerd Bouma; Warren Strober
Journal:  Nat Rev Immunol       Date:  2003-07       Impact factor: 53.106

Review 7.  Growth factors in development: the role of TGF-beta related polypeptide signalling molecules in embryogenesis.

Authors:  B L Hogan; M Blessing; G E Winnier; N Suzuki; C M Jones
Journal:  Dev Suppl       Date:  1994

8.  Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist.

Authors:  S Gillessen; D Carvajal; P Ling; F J Podlaski; D L Stremlo; P C Familletti; U Gubler; D H Presky; A S Stern; M K Gately
Journal:  Eur J Immunol       Date:  1995-01       Impact factor: 5.532

9.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

Authors:  F Powrie; M W Leach; S Mauze; L B Caddle; R L Coffman
Journal:  Int Immunol       Date:  1993-11       Impact factor: 4.823

10.  Antibodies to interleukin 12 abrogate established experimental colitis in mice.

Authors:  M F Neurath; I Fuss; B L Kelsall; E Stüber; W Strober
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  9 in total

Review 1.  The genomic landscape of human immune-mediated diseases.

Authors:  Xin Wu; Haiyan Chen; Huji Xu
Journal:  J Hum Genet       Date:  2015-08-20       Impact factor: 3.172

2.  Host-dependent control of early regulatory and effector T-cell differentiation underlies the genetic susceptibility of RAG2-deficient mouse strains to transfer colitis.

Authors:  V Valatas; J He; A Rivollier; G Kolios; K Kitamura; B L Kelsall
Journal:  Mucosal Immunol       Date:  2012-11-14       Impact factor: 7.313

3.  A distal enhancer in Il12b is the target of transcriptional repression by the STAT3 pathway and requires the basic leucine zipper (B-ZIP) protein NFIL3.

Authors:  Amber M Smith; Joseph E Qualls; Kevin O'Brien; Liza Balouzian; Peter F Johnson; Stacey Schultz-Cherry; Stephen T Smale; Peter J Murray
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

Review 4.  TRPA1: A gatekeeper for inflammation.

Authors:  Diana M Bautista; Maurizio Pellegrino; Makoto Tsunozaki
Journal:  Annu Rev Physiol       Date:  2012-09-27       Impact factor: 19.318

5.  Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation.

Authors:  E Marks; C Naudin; G Nolan; B J Goggins; G Burns; S W Mateer; J K Latimore; K Minahan; M Plank; P S Foster; R Callister; M Veysey; M M Walker; N J Talley; G Radford-Smith; S Keely
Journal:  Mucosal Immunol       Date:  2017-01-25       Impact factor: 7.313

6.  Analysis of IL12B gene variants in inflammatory bowel disease.

Authors:  Jürgen Glas; Julia Seiderer; Johanna Wagner; Torsten Olszak; Christoph Fries; Cornelia Tillack; Matthias Friedrich; Florian Beigel; Johannes Stallhofer; Christian Steib; Martin Wetzke; Burkhard Göke; Thomas Ochsenkühn; Julia Diegelmann; Darina Czamara; Stephan Brand
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 7.  Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research.

Authors:  Enrico Radaelli; Sara F Santagostino; Rani S Sellers; Cory F Brayton
Journal:  ILAR J       Date:  2018-12-31

8.  Role of IL-12p40 in cervical carcinoma.

Authors:  H J M A A Zijlmans; S Punt; G J Fleuren; J B Trimbos; G G Kenter; A Gorter
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

9.  The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease.

Authors:  Hye Won Lee; Sook Hee Chung; Chang Mo Moon; Xiumei Che; Seung Won Kim; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.